title: Neurotrophic factors enhance the survival of muscle fibers in EDL, but not SOL, after neonatal nerve injury.
abstract: Neonatal sciatic nerve crush results in a sustained reduction of the mass of both extensor digitorum longus (EDL) and soleus (SOL) muscles in the rat. Type IIB fibers are selectively lost from EDL. We have investigated the effects of ciliary neurotrophic factor (CNTF) combined with neurotrophin (NT)-3 or NT-4 on muscle mass, as well as the number, cross-sectional area, and distribution of muscle fiber types and the number of motor neurons innervating EDL and SOL 3 mo after transient axotomy 5 days after birth. Both NT treatments prevented the axotomy-induced loss of muscle mass in both EDL and SOL and of total number of muscle fibers in EDL but not in SOL. Although IIB fiber loss was not prevented, both NT treatments resulted in altered fiber type distribution. Both NT combinations also reduced the loss of EDL motor neurons. These data suggest that a differential distribution of NT receptors on either motor neurons or muscle fibers may lead to different levels of susceptibility to neonatal axotomy.
authors.affiliation: Department of Cellular and Molecular Medicine, University of Ottawa, Ontario K1H-8M5, Canada.
authors.forename: Kambiz
authors.initials: K
authors.lastname: Mousavi
authors.forename: Wilson
authors.initials: W
authors.lastname: Miranda
authors.forename: David J
authors.initials: DJ
authors.lastname: Parry
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D019771:Axotomy; D002470:Cell Survival / Q000187:drug effects; D020934:Ciliary Neurotrophic Factor / Q000494:pharmacology; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D007150:Immunohistochemistry; D009046:Motor Neurons / Q000187:drug effects / Q000473:pathology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D018485:Muscle Fibers, Skeletal / Q000145:classification / Q000187:drug effects* / Q000473:pathology; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000294:innervation / Q000473:pathology / Q000503:physiopathology; D018995:Myosin Heavy Chains / Q000096:biosynthesis; D009409:Nerve Crush; D009414:Nerve Growth Factors / Q000494:pharmacology*; D020933:Neurotrophin 3 / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020426:Sciatic Neuropathy / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
chemical_list: D020934:Ciliary Neurotrophic Factor; D009414:Nerve Growth Factors; D020933:Neurotrophin 3; D018995:Myosin Heavy Chains; C073922:neurotrophin 4